A case report of tumor-induced osteomalacia: Eight year followed-up

Journal of the Medical Association of Thailand

Volumn 91, Issue 12, 2008, Pages 1900-1903

  Ratanasuwan, Tanaporn ^a,c   Chetsurakarn, Somchai ^a   Ongphiphadhanakul, Boonsong ^b   Damrongkitchaiporn, Somneok ^b  

^a LERDSIN GENERAL HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Fibroblast growth factor 23; Hemangiopericytoma; Hypophosphatemic ricket; Oncogenic osteomalacia; Tumor induced osteomalacia

Indexed keywords

CALCIUM CARBONATE; PHOSPHATE; PHOSPHORUS; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23;

ADULT; ARTICLE; BIOCHEMISTRY; BONE DENSITOMETRY; BONE DENSITY; BONE DISEASE; BONE PAIN; BONE RADIOGRAPHY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; KYPHOSCOLIOSIS; LABORATORY TEST; MALE; MUSCLE WEAKNESS; ONCOGENIC OSTEOMALACIA; PATHOLOGIC FRACTURE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY; TUMOR VOLUME; HYPOPHOSPHATEMIA; MIDDLE AGED; NEOPLASM; OSTEOMALACIA; PATHOPHYSIOLOGY; RICKETS; RISK FACTOR;

FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HEMANGIOPERICYTOMA; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; NEOPLASMS; OSTEOMALACIA; RICKETS; RISK FACTORS;

EID: 58949089501     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Miyauchi A, Fukase M, Tsutsumi M, Fujita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J Clin Endocrinol Metab 1988; 67: 46-53.
2. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001; 98: 6500-5.
3. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000; 26: 345-8.
4. Drezner MK. PHEX gene and hypophosphatemia. Kidney Int 2000; 57: 9-18.
5. Strewler GJ. FGF23, hypophosphatemia, and rickets: has phosphatonin been found? Proc Natl Acad Sci U S A 2001; 98: 5945-6.
6. Drezner MK. Tumor-induced rickets and osteomalacia. In: Favus MJ, editor. Primer in the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott-Raven; 1996: 319-25.
7. Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK. Oncogenic osteomalacia associated with mesen- chymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) 2001; 54: 551-4.
8. Spitz FR, Bouvet M, Pisters PW, Pollock RE, Feig BW. Hemangiopericytoma: a 20-year single - institution experience. Ann Surg Oncol 1998; 5: 350-5.
9. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106-20.
10. Craven JP, Quigley TM, Bolen JW, Raker EJ. Current management and clinical outcome of hemangiopericytomas. Am J Surg 1992; 163: 490-3.
11. Billings KR, Fu YS, Calcaterra TC, Sercarz JA. Hemangiopericytoma of the head and neck. Am J Otolaryngol 2000; 21: 238-43.